Actively Recruiting
Seroma of the Mammary Gland
Led by University Hospital Augsburg · Updated on 2025-02-28
2000
Participants Needed
1
Research Sites
169 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study is designed as international, prospective, minimal interventional study in cooperation with EUBREAST e.V. (European Breast Cancer Research Association of Surgical Trialists). Furthermore, it is planned to initiate a registry for postoperative breast seromas.
CONDITIONS
Official Title
Seroma of the Mammary Gland
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Written informed consent
- Age 18 years or older
- Diagnosis of ductal carcinoma in situ or primary breast cancer at any stage including all histopathological subtypes
- Planned surgery including ablatio or subcutaneous mastectomy with implant or expander insertion
- For control groups, planned surgery with implant or expander insertion with or without subcutaneous mastectomy
You will not qualify if you...
- Younger than 18 years
- Male sex
- Breast cancer patients planned for breast conserving therapy
- Recurrent breast cancer
- History of breast surgery
- Diagnosis of lobular carcinoma in situ only
- Pregnant at time of diagnosis
- Known immunodeficiency
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Augsburg, Department of Gynecology and Obstetrics
Augsburg, Bavaria, Germany, 86156
Actively Recruiting
Research Team
N
Nina Ditsch, Prof.
CONTACT
M
Melitta Köpke, Dr. med.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here